Specialist diagnosis and surgical management of prostate, kidney, bladder and testicular cancers.
Urological cancers affect organs of the urinary tract and the reproductive system. Early diagnosis and accurate staging are essential to determine the most appropriate treatment pathway.
Management is tailored to the specific cancer type, stage of disease, patient health and long-term functional considerations. Treatment may involve surgery, surveillance, or coordination with oncology specialists where additional therapy is required.
Assessment and surgical management of cancer affecting the prostate gland.
Diagnosis and treatment of tumours arising within the kidney.
Evaluation and management of cancer involving the bladder lining.
Cancer affecting the lining of the kidneys or ureters.
Assessment and surgical treatment of tumours affecting the testicle.
Evaluation of kidney or prostate abnormalities found during imaging.
Investigation of ongoing or unexplained blood in the urine.
Evaluation of urinary symptoms, medical history and risk factors to assess possible benign or malignant prostate conditions.
PSA testing and blood analysis may help identify prostate enlargement, inflammation or possible prostate cancer. Note that PSA may be in the normal range and still be of clinical concern.
Ultrasound or MRI may be used to assess prostate size, bladder function and structural changes.
When PSA levels remain elevated or imaging findings raise concern, a prostate biopsy may be recommended to confirm or exclude prostate cancer.
Treatment depends on cancer type, stage and individual patient factors.
Evaluation may include digital rectal examination, PSA testing, MRI and prostate biopsy where indicated.
Assessment includes contrast-enhanced CT imaging, renal function testing and review of tumour characteristics.
Robotic kidney surgery may allow tumour removal while preserving healthy kidney tissue when possible.
Management depends on tumour grade, stage and recurrence risk.
Structured follow-up is important due to the recurrence risk.
Evaluation includes clinical examination, scrotal ultrasound and tumour marker testing.
Further assessment may be required when:
Early evaluation allows appropriate staging and treatment planning.
Management may include:
Contact the practice to make an enquiry or arrange an appointment.
No. Some cancers may be suitable for active surveillance or non-surgical treatment depending on stage, tumour characteristics and patient health.
Staging usually involves imaging such as CT or MRI, laboratory testing and biopsy results to determine how advanced the cancer is.
In some cases, treatment may involve coordination with radiation oncologists or medical oncologists to ensure comprehensive care.
Follow-up schedules vary depending on cancer type and stage, but regular monitoring is important to detect recurrence early.
You should seek medical review if you experience blood in the urine, persistent urinary symptoms, elevated PSA levels, or a new testicular lump.
